Corporate mission
Hubro Bioscience is founded on its frameshift mutation targeting technology platforms. The overarching goal of the company is to develop vaccines and bio-marker tests for prevention of cancer. Through further development of the capacities within its platforms, the company seeks to develop strong product candidates and explore these opportunities alone and/or in partnership with other companies and institutions.
There is a wide scope of strategic and operational possibilities for the company, and it will tirelessly explore the most interesting paths, and create results which will provide better cancer care, improve the life quality of families at high-risk of cancer and deliver attractive returns to its shareholders.
